Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-117,923
Closed -$5.07M 195
2026
Q1
$5.07M Buy
117,923
+71,423
+154% +$3.07M 0.21% 64
2025
Q4
$2.04M Sell
46,500
-35,196
-43% -$1.46M 0.09% 124
2025
Q3
$3.37M Buy
81,696
+5,386
+7% +$216K 0.19% 71
2025
Q2
$3.36M Sell
76,310
-43,894
-37% -$1.75M 0.15% 75
2025
Q1
$4.44M Buy
120,204
+9,447
+9% +$337K 0.17% 65
2024
Q4
$3.69M Buy
+110,757
New +$3.59M 0.13% 72

Other funds holding EXEL

Ruffer LLP's EXEL Position: Q2 2026 in Review

Ruffer LLP sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 117,923 shares — an estimated $5.07M sold.

Ruffer LLP first reported a position in EXEL in Q4 2024 and held it in 6 quarters. The position peaked at $5.07M in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Ruffer LLP reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • Ruffer LLP sold 117,923 Exelixis shares in Q2 2026, an estimated $5.07M.
  • Ruffer LLP first reported a position in Exelixis in Q4 2024 and held it in 6 quarters.
  • Ruffer LLP's Exelixis position peaked at $5.07M in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Ruffer LLP's 13F filing for Q2 2026, filed 30 Jul 2026.